Document:

Exhibit 10.2

    

     

    

    Execution Version

    

    

    RESALE REGISTRATION RIGHTS AGREEMENT

    

    

    THIS RESALE REGISTRATION RIGHTS AGREEMENT, dated as of December 15, 2021 (this “Agreement”), has been entered into by and between VENUS CONCEPT INC., a Delaware corporation (the “Company”) and the Purchasers (as defined below).

    

    

    BACKGROUND

    

    

    In connection with the Stock Purchase Agreement, dated as of December 15, 2021 (the “SPA”), by and between the Purchasers (as defined below) and the Company, pursuant to which the Purchasers have agreed to purchase from the Company 9,808,418 shares of common stock of the Company (“Common Stock”) and 3,790,755 shares of nonvoting convertible preferred stock of the Company (the “Preferred Stock”), and the
      Company has agreed to provide to the Purchasers certain resale registration rights under the Securities Act of 1933, as amended, and the rules and regulations thereunder (together, the “Securities Act”), and applicable state securities laws with respect to the Covered Shares (as defined below).

    

    

    AGREEMENT

    

    

    In light of the above, the Company and the Purchasers hereby agree as follows:

    

    

    
      1.           Definitions.

    

    

    

    As used in this Agreement, the following terms will have the respective meanings set forth in this Section 1:

    

    

    “Agreement” has the meaning set forth in the preamble.

    

    

    “Advice” has the meaning set forth in Section 2(d)(iv).

    

    

    “As-Converted Covered Share Ownership Percentage” means with respect
      to any Holder(s) as of any time, a fraction (a) whose numerator is the aggregate number of Covered Shares owned by such Holder(s) as of such time; and (b) whose denominator is the aggregate number of Covered Shares that are then outstanding held by
      all Holders under this Agreement; provided, however, that for purposes of this definition, Registrable Securities not relating to any Preferred Stock or Covered Shares issued pursuant to the
      SPA will be disregarded.

    

    

    “Blue Sky” has the meaning set forth in Section 3(m).

    

    

    “Business Day” means (i) a day on which the Common Stock is traded on
      a Trading Market, (ii) if the Common Stock is not listed on any Trading Market, a day on which the Common Stock is quoted in the over-the-counter market as reported by the National Quotation Bureau Incorporated (or any similar organization or agency
      succeeding to its functions of reporting prices) or (iii) in the event that the Common Stock is not listed or quoted as set forth in (i) and (ii) hereof, any day other than a Saturday, a Sunday or a day on which banking institutions in The City of
      New York are authorized or required by law, regulation or executive order to remain closed.

    

    

    “Claim” has the meaning set forth in Section 5(b).

    

    

    “Commission” means the Securities and Exchange Commission or any
      successor agency.

    

    

    “Common Stock” means the Company’s common stock, par value $0.0001 per
      share.

    

    

    
      
        

    

    
    “Covered Share” means (i) any shares of Common Stock or (ii) any share
      of Common Stock issued or issuable upon conversion of the Preferred Stock.

    

    

    “Company” has the meaning set forth in the preamble.

    

    

    “Discontinuance Notice” has the meaning set forth in Section 3(d).

    

    

    “Effective Date” means, with respect to any Registration Statement,
      the date on which the Commission first declares effective such Registration Statement.

    

    

    “Effectiveness Deadline” means, with respect to a Registration
      Statement filed pursuant to Section 2(a), ninety (90) calendar days after the Filing Deadline in the case of a filing on Form S-3 and one hundred twenty (120) calendar days after the Filing Deadline in the case of a filing on Form S-1.

    

    

    “Effectiveness Period” has the meaning set forth in Section 2(a).

    

    

    “Exchange Act” means the Securities Exchange Act of 1934, as amended,
      and the rules and regulations promulgated thereunder.

    

    

    “Filing Deadline” means January 14, 2022.

    

    

    “FINRA” means the Financial Industry Regulatory Authority, Inc. or any
      successor organization performing similar functions.

    

    

    “Holder” or “Holders” means the holder or holders, as the case may be, from time to time of Registrable Securities.

    

    

    “Indemnified Party” has the meaning set forth in Section 5(c).

    

    

    “Indemnifying Party” has the meaning set forth in Section 5(c).

    

    

    “Losses” has the meaning set forth in Section 5(a).

    

    

    “Person” or “person” means any individual, corporation, partnership, limited liability company, joint venture, association, joint-stock company, trust, unincorporated organization or government or other agency or political
      subdivision thereof. Any division or series of a limited liability company, limited partnership or trust will constitute a separate “person” under this Agreement.

    

    

    “Plan of Distribution” has the meaning set forth in Section 2(a).

    

    

     “Preferred Stock” has the meaning set forth in the preamble.

    

    

    “Proceeding” means an action, claim, suit, investigation or proceeding
      (including, without limitation, an investigation or partial proceeding, such as a deposition), whether commenced or threatened.

    

    

    “Prospectus” means the prospectus included in a Registration Statement
      (including, without limitation, any preliminary prospectus, any free-writing prospectus and any prospectus that includes any information previously omitted from a prospectus filed as part of an effective registration statement under the Securities
      Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to such prospectus,
      including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such prospectus.

    

    

    
      2

      
        

    

    “Purchaser” is

      any of one of the Purchasers.

    

    

    “Purchasers” means the purchasers of the Preferred Stock identified on
      the signature pages to the SPA and each successor and assignee that becomes party to the SPA.

    

    

    “Registrable Securities” means any Covered Shares and any shares of
      capital stock issued or issuable with respect to the foregoing as a result of any stock split, stock dividend, recapitalization, exchange or similar event or otherwise.  As to any particular Registrable Securities, such securities shall cease to be
      Registrable Securities when (i) the Commission has declared a Registration Statement covering such securities effective and such securities have been disposed of pursuant to such effective Registration Statement; (ii) such securities are sold under
      circumstances in which all of the applicable conditions of Rule 144 under the Securities Act are met and the legend restricting further transfer has been removed from the certificate for such securities; or (iii) such securities are no longer
      outstanding.

    

    

    “Registration Default” has the meaning set forth in Section 2(c)(iv).

    

    

    “Registration Statement” means a registration statement filed pursuant
      to the terms hereof and which covers the resale by the Holders, including the Prospectus, amendments and supplements to such registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto and all material
      incorporated by reference (or deemed to be incorporated by reference) therein.  For the avoidance of doubt, “Registration Statement” means the initial registration statement
      described above in this paragraph and any additional registration statement or registration statements that are needed to sell additional Registrable Securities with the effect that the obligations of the Company under this Agreement also extend to
      such additional registration statement or registration statements, in all cases, as specified in this Agreement.

    

    

    “Rule 144” means Rule 144 promulgated by the Commission pursuant to
      the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

    

    

    “Rule 415” means Rule 415 promulgated by the Commission pursuant to
      the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

    

    

    “Rule 424” means Rule 424 promulgated by the Commission pursuant to
      the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

    

    

    “SEC Guidance” means (i) any publicly-available written or oral
      guidance of the SEC staff, or any comments, requirements or requests of the SEC staff whether formally or informally or publicly or privately and (ii) the Securities Act.

    

    

    “Securities Act” has the meaning set forth in the preamble.

    

    

    “Selling Holder Questionnaire” has the meaning set forth in Section
      2(d)(i).

    

    

    “Selling Securityholders” has the meaning set forth in Section 3(b).

    

    

     “SPA” has the meaning set forth in the preamble.

    

    

    “Subsequent Form S-3” has the meaning set forth in Section 3(n).

    

    

    “Suspension Notice” has the meaning set forth in Section 2(b).

    

    

    
      3

      
        

    

    “Suspension Period” has the meaning set forth in Section 2(b).

    

    

    “Trading Market” means whichever of the NYSE American, New York Stock
      Exchange, the Nasdaq Global Market, the Nasdaq Capital Market, Nasdaq Global Select Market or such other United States registered national securities exchange on which the Common Stock is listed or quoted for trading on the date in question.\

    

    

     “Underwritten Offering” shall mean a registration in which securities
      of the Company are sold to an Underwriter in a firm commitment underwriting for distribution to the public.

    

    

    
      2.           Registration.

    

    

    

    (a)          Mandatory

          Registration.

    

    

    (i)          On or prior to the Filing Deadline,
          the Company will prepare and file with the Commission a Registration Statement covering the resale of all Registrable Securities for an offering to be made on a continuous basis pursuant to Rule 415.  The Registration Statement will be on Form
          S-3 (except if the Company is not then eligible to register for resale the Registrable Securities on Form S-3, in which case such registration will be on Form S-1, and if for any reason the Company is not then eligible to register for resale the
          Registrable Securities on Form S-1,  then  another appropriate form for such purpose) and will contain (except if otherwise required pursuant to written comments received from the Commission upon a review of such Registration Statement) a “Plan of Distribution” section, substantially in the form attached hereto as Annex A, as the same may be amended in accordance with the provisions of this Agreement.  The Company will use its
          reasonable best efforts to cause the Registration Statement to be declared effective under the Securities Act as soon as possible but, in any event, no later than the Effectiveness Deadline, and will use their reasonable best efforts to keep the
          Registration Statement (or a Subsequent Form S-3) continuously effective under the Securities Act until such date when all Registrable Securities covered by the Registration Statement cease to be Registrable Securities as determined by the
          counsel to the Company (the “Effectiveness Period”).

    

    

    (ii)          Notwithstanding the registration
          obligations set forth in this Section 2(a), if the Commission informs the Company that all of the Registrable Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration
          statement, the Company agrees to promptly inform each of the Holders thereof and use its commercially reasonable efforts to file amendments to the Initial Registration Statement as required by the Commission, covering the maximum number of
          Registrable Securities permitted to be registered by the Commission, on Form S-3 (or Form S-1, if available) or such other form available to register for resale the Registrable Securities as a secondary offering; provided, however, that prior to
          filing such amendment, the Company shall be obligated to use diligent efforts to advocate with the Commission for the registration of all of the Registrable Securities in accordance with the SEC Guidance, including without limitation, Compliance
          and Disclosure Interpretation 612.09.

    

    

    (iii)        Notwithstanding any other provision
          of this Agreement, if the Commission or any SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be registered on a particular Registration Statement as a secondary offering (and notwithstanding that the
          Company used diligent efforts to advocate with the Commission for the registration of all or a greater portion of Registrable Securities), unless otherwise directed in writing by a Holder as to its Registrable Securities, the number of
          Registrable Securities to be registered on such Registration Statement will be reduced by reducing or eliminating any securities to be included other than Registrable Securities.

    

    

    
      4

      
        

    

    (iv)         In the event of a cutback under
          this Section 2(a), the Company shall give the Holder at least five (5) Trading Days prior written notice along with the calculations as to such Holder’s allotment. In the event the Company amends the Registration Statement in accordance with the
          foregoing, the Company will use its best efforts to file with the Commission, as promptly as allowed by Commission or SEC Guidance provided to the Company or to registrants of securities in general, one or more registration statements on Form S-3
          (or Form S-1 if available) or such other form available to register for resale those Registrable Securities that were not registered for resale on the Initial Registration Statement, as amended.

    

    

    (b)         Suspension Periods.  Notwithstanding Section 2(a), the Company may, at any time, delay the filing or delay or suspend the effectiveness of a Registration Statement or, without suspending
      such effectiveness, deliver a notice (a “Suspension Notice”) that instructs any selling Holders not to sell any securities included in the Registration Statement or delay
      the filing of any amendment or supplement pursuant to Section 3, if the board of directors of the Company has determined and promptly notifies the selling Holders in writing that in its reasonable good faith judgment (i) pending corporate development
      with respect to the Company that the Company believes may be material and that, in the determination of the Company, makes it materially detrimental to the Company to allow continued availability of a Registration Statement or Prospectus or (ii) such
      registration could reasonably be expected to materially interfere with any material financing, acquisition, corporate reorganization, merger, tender offer or other significant transaction involving the Company (a “Suspension Period”), by providing the selling Holders with written notice of such Suspension Period and the reasons therefor.  The Company will use its reasonable best efforts to provide such notice at
      least ten (10) Business Days prior to the commencement of such a Suspension Period; provided, however, that in any event the Company will provide such notice no later than the commencement of such Suspension Period; provided, further, that in no
      event will a Suspension Period exceed 30 days and in no event shall the total number of days subject to a Suspension Period during any consecutive 12-month period exceed 45 days. Any Suspension Period will not be deemed to end until the Holders have
      received a notice from the Company stating that such Suspension Period has ended.

    

    

    (c)         Damages.  The parties hereto agree that, subject to Section 2(d), the Holders will suffer damages if the Company fails to fulfill its obligations under this Section 2 and that, in such
      case, it would not be feasible to ascertain the extent of such damages with precision.  Accordingly, if:

    

    

    (i)            the Company does not file a
          Registration Statement by the Filing Deadline;

    

    

    (ii)           a Registration Statement is not
          declared effective by the Commission on or before the applicable Effectiveness Deadline;

    

    

    (iii)          the Company extends any
          Suspension Period beyond 45 days during any consecutive 12-month period; or

    

    

    (iv)          a Registration Statement is filed
          and declared effective but, during the applicable Effectiveness Period, a Registration Statement is not effective for any reason or the Prospectus contained therein is not available for use for any reason, including by reason of its withdrawal or
          termination pursuant to Section 3(e), or, other than by reason of a Suspension Period as provided in Section 2(b), will fail to be usable for its intended purpose without such disability being cured within ten (10) Business Days by an effective
          post-effective amendment to such Registration Statement, a supplement to the Prospectus, a report filed with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act that cures such failure or the effectiveness of a
          Subsequent Form S-3, and either (x) the Company fails for any reason to satisfy the requirements of Rule 144(c)(1), including, without limitation, the failure to satisfy the current public information requirement under Rule 144(c); or (y) the
          Company fails to satisfy any condition set forth in Rule 144(i)(2) as a result of which any of the Holders are unable to sell Registrable Securities without restriction under Rule 144 (including, without limitation, volume restrictions) (each
          such event referred to in foregoing clauses (i) through (iv), a “Registration Default”), then in such event as partial relief for the damages to any Holder by reason of
          any such delay in or reduction of its ability to sell the Registrable Securities and not as a penalty (which remedy will not be exclusive of any other remedies available at law or equity), the Company hereby agrees to make pro rata payments to
          each Holder, subject to Section 2(d), as liquidated damages and not as a penalty, an additional amount equal to 0.5% of the aggregate amount invested by such Holder for each 90-day period (or pro rata for any portion thereof) following the
          occurrence of any Registration Default and shall be increased by 0.5% during each subsequent 90-day period (or pro rata for any portion thereof), provided that in no event shall the additional amount per 90-day period exceed 2.0% and in no event
          shall the aggregate additional amount due pursuant to this Section 2(c)(iv) exceed 5.0% of the aggregate amount invested by such Holder.  Such payments shall constitute the Holder’s exclusive monetary remedy for such events, but shall not affect
          the right of the Holders to seek injunctive relief.  The amounts payable as liquidated damages pursuant to this paragraph shall be paid monthly within three (3) Business Days of the last day of each month following the commencement of the
          payments.  Such payments shall be made to each Holder in cash. Interest shall accrue at the rate of 1% per month on any such liquidated damages payments that shall not be paid by the due date until such amount is paid in full.

    

    

    
      5

      
        

    

    (d)          Holders’ Agreements.  It will be a condition of each Holder’s rights under this Agreement, and each Holder agrees, as follows:

    

    

    (i)           Cooperation

              & Selling Holder Questionnaire.  Such Holder will cooperate with the Company by, with reasonable promptness, supplying information and executing documents relating to such selling Holder or the securities of the Company owned
          by such selling Holder in connection with such registration which are customary for offerings of this type or is required by applicable laws or regulations, including but not limited to furnishing to the Company a completed questionnaire in the
          form attached to this Agreement as Annex B (a “Selling Holder Questionnaire”).  The Company will not be required to include the Registrable Securities of a Holder in a
          Registration Statement and will not be required to pay any damages under Section 2(c) to any Holder who fails to furnish to the Company a fully completed Selling Holder Questionnaire at least five (5) Business Days prior to the applicable Filing
          Deadline.

    

    

    (ii)          Undertakings. 

          Such selling Holder will enter into any undertakings and take such other action relating to the conduct of the proposed offering which the Company may reasonably request as being necessary to insure compliance with federal and state securities
          laws and the rules or other requirements of FINRA.

    

    

    (iii)         Shelf

              Sales.  In connection with and as a condition to the Company’s obligations with respect to any shelf Registration Statement, each Holder covenants and agrees that it will not offer or sell any such Registrable Securities under the
          Registration Statement until the Registration Statement has been declared effective by the Commission and such Holder has provided a written notice to the Company of such proposed sale.  The Company and the Holders acknowledge and agree that in
          no way shall this clause limit Holder’s ability to sell securities without using the Registration Statement.

    

    

    (iv)        Discontinuance

              of Sales.  Each Holder agrees by its acquisition of such Registrable Securities that, upon receipt of a Suspension Notice or a Discontinuance Notice from the Company, such Holder will forthwith discontinue any offers and sales of
          such Registrable Securities under the Registration Statement until such Holder’s receipt of the copies of the supplemented Prospectus and/or amended Registration Statement or until it is advised in writing (the “Advice”) by the Company that the use of the applicable Prospectus may be resumed, and, in either case, has received copies of any additional or supplemental filings that are incorporated or deemed
          to be incorporated by reference in such Prospectus or Registration Statement.  The Company and the Holders acknowledge and agree that in no way shall this clause limit Holder’s ability to sell securities without using the Registration Statement.

    

    

    
      6

      
        

    

    (e)          Piggyback Registrations.  Without limiting any obligation of the Company, if the Company shall determine to prepare and file with the Commission a registration statement relating to an
      offering for its own account or the account of others under the Securities Act of any of its equity or equity-linked securities (other than on Form S-4 or Form S-8 (each as promulgated under the Securities Act) or their then equivalents relating to
      equity or equity-linked securities to be issued solely in connection with any acquisition of any entity or business (or a business combination subject to Rule 145 under the Securities Act) or equity or equity-linked securities issuable in connection
      with the Company’s stock option or other employee benefit plans), or a dividend reinvestment or similar plan or rights offering, then the Company shall deliver to each Holder a written notice of such determination and, if within fifteen (15) calendar
      days after the date of the delivery of such notice, any such Holder shall so request in writing, the Company shall include in such registration statement or offering statement all or any part of such Registrable Securities that such Holder requests
      to be registered (a “Piggyback Registration”). The Company shall, in good faith, cause such Registrable Securities to be included in such Piggyback Registration and shall use its best efforts
      to cause the managing underwriter or underwriters of a proposed Underwritten Offering in connection with such Piggyback Registration to permit the Registrable Securities requested by the Holders pursuant to this Section

          2(e) to be included in a Piggyback Registration on the same terms and conditions as any similar securities of the Company included in such registration and to permit the sale or other disposition of such Registrable Securities in
      accordance with the intended method(s) of distribution thereof. All such Holders proposing to distribute their Registrable Securities through an Underwritten Offering under this Section 2(e) shall enter
      into an underwriting agreement in customary form with the underwriter(s) selected for such Underwritten Offering by the Company.  The Company may postpone or withdraw the filing or the effectiveness of a piggyback registration at any time in its sole
      discretion. The Company shall not grant piggyback registration rights to any holders of its Common Stock or securities that are convertible into its Common Stock that are senior to the rights of the Holders set forth in this Section 2(e).

    

    

    
      3.           Registration Procedures.  In connection with the Company’s obligations to effect a registration pursuant to
        Section 2(a), the Company and, as applicable, the Holders, will do the following:

    

    

    

    (a)          FINRA Cooperation.  The Company and the Holders will cooperate and assist in any filings required to be made with FINRA.

    

    

    (b)         Right to Review Prior Drafts.  Not less than ten (10) Business Days prior to the filing of a Registration Statement or any related Prospectus or any amendment or supplement thereto, the Company will
      furnish to each Holder copies of the “Selling Securityholders” and “Plan of Distribution”
      sections of such documents (together with drafts of the Registration Statement or any related Prospectus or any amendment or supplement thereto) in the form in which the Company proposes to file them, which sections and documents will be subject to
      the review of each such Holder.  Each Holder will provide comments, if any, within five (5) Business Days after the date such materials are provided.  The Company will not file a Registration Statement, any Prospectus or any amendments or supplements
      thereto in which the “Selling Securityholders” or the “Plan of Distribution” sections thereof
      differ in any material respect from the disclosure received from a Holder in its Selling Holder Questionnaire (as amended or supplemented) or otherwise differ in any material respect from the drafts previously received by such Holder.

    

    

    (c)         Right to Copies.  The Company will furnish to each Holder and the managing underwriters, if any, without charge, (i) at least one (1) conformed copy of each Registration Statement and each amendment
      thereto and all exhibits to the extent requested by such Holder (excluding those previously furnished or incorporated by reference) promptly after the filing of such documents with the Commission, except if such documents are available on EDGAR; and
      (ii) as many copies of each Prospectus or Prospectuses (including each form of prospectus) and each amendment or supplement thereto as such Holder may reasonably request.  The Company hereby consents to the use of such Prospectus and each amendment
      or supplement thereto by each of the selling Holders or managing underwriters, as applicable, in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any amendment or supplement thereto.

    

    

    
      7

      
        

    

    (d)         Notices.  The Company will notify each Holder covered by the Registration Statement as promptly as reasonably practicable: (A) when the Prospectus or any prospectus supplement or post-effective
      amendment has been filed, and with respect to the Registration Statement or any post-effective amendment, when the same has become effective; (B) of any request by the Commission for any amendments or supplements to the Registration Statement or the
      Prospectus or for additional information; (C) of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or the initiation of any proceedings for that purpose; (D) if, at any time prior to the
      closing contemplated by the SPA, it becomes aware that the representations and warranties of the Company contained in such agreement cease to be true and correct; (E) of the receipt by the Company of any notification with respect to the suspension of
      the qualification of the Registrable Securities for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; (F) of the happening of any event which it believes may make any statement made in the Registration
      Statement, the Prospectus or any document incorporated therein by reference untrue, or of any material misstatement or omission, and which requires the making of any changes in the Registration Statement, the Prospectus or any document incorporated
      therein by reference in order to make the statements therein not misleading; (G) upon the occurrence of a Suspension Period (items (C) through and including (G) being a “Discontinuance

        Notice”); and (H) upon the conclusion of a Suspension Period.

    

    

    (e)         Withdrawal of Suspension Orders. The Company will use its reasonable best efforts to respond as promptly as reasonably possible to any comments received from the Commission with respect to any
      Registration Statement or any amendment thereto and to obtain the withdrawal of any order suspending the effectiveness of the Registration Statement or the suspension of the qualification of the Registrable Securities for sale in any jurisdiction, or
      to prevent any such suspension.

    

    

    (f)        Supplements & Amendments.  Subject to Sections 2(a), if required by applicable federal securities laws, based on the advice of the Company’s counsel, the Company will prepare a supplement or
      post-effective amendment to a Registration Statement, the related Prospectus or any document incorporated therein by reference or file any other required document or, if necessary, renew or refile a Registration Statement prior to its expiration, so
      that, as thereafter delivered to the purchasers of the Registrable Securities, (A) the Prospectus will not contain an untrue statement of a material fact or omit to state any material fact necessary to make the statements therein not misleading; (B)
      such Registration Statement remains continuously effective as to the applicable Registrable Securities for its applicable Effectiveness Period; (C) the related Prospectus may be supplemented by any required prospectus supplement, and as so
      supplemented may be filed pursuant to Rule 424 and (D) the Prospectus will be supplemented, if necessary, to update the disclosure of the number of shares that each Holder intends to sell, reflecting prior resales in accordance with guidance of the
      staff of the Commission (as such guidance may be substituted for, amended or supplemented by the staff of the Commission after the date of this Agreement).  Furthermore, subject to a Holder’s compliance with its obligations under Section 2(d)(i), the
      Company will take such actions as are required to name such Holder as a selling Holder in a Registration Statement or any supplement thereto and to include (to the extent not theretofore included) in such Registration Statement the Registrable
      Securities identified in such Holder’s Selling Holder Questionnaire.

    

    

    (g)         Listing.  The Company will use its commercially reasonable  efforts to cause all Covered Shares that constitute Registrable Securities covered by the Registration Statement to be listed on each
      securities exchange on which identical securities issued by the Company are then listed if requested by the Holder thereof and, if not so listed, to be approved for listing on the national securities exchange on which the Company’s Common Stock is
      then listed.

    

    

    (h)          Transfer Agent & Registrar.  The Company will provide and cause to be maintained a transfer agent and registrar for all Registrable Securities covered by such Registration Statement from and after
      a date not later than the Effective Date of such Registration Statement.

     

    

    
      8

      
        

    

    (i)          Certificates.  The Company will cooperate with the Holders to facilitate the timely preparation and delivery of any certificates representing Registrable Securities to be delivered to a transferee
      pursuant to any Registration Statement, which certificates will be free of all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered in such names as any such Holders may reasonably request.

    

    

    (j)          CUSIPs.  The Company, if necessary, will use its best efforts to provide a CUSIP number for the Registrable Securities, not later than the Effective Date of the Registration Statement.

    

    

    (k)          [Reserved.]

    

    

    (l)         Legal Counsel.  Holders will have the right to select one legal counsel, at the Company’s reasonable expense pursuant to Section 4, to review any Registration Statement or Prospectus prepared pursuant
      to Section 2 or this Section 3, which will be such counsel as designated by the Holders of a majority of the Registrable Securities then outstanding.  The Company will reasonably cooperate with such legal counsel’s reasonable requests in performing
      their obligations under this Agreement.

    

    

    (m)        Blue Sky.  If at any time the Registrable Securities are not “Covered Securities within the meaning of Rule 146 of the Securities Act, the Company will, prior to any public offering of Registrable
      Securities, use its reasonable best efforts to register or qualify or cooperate with the selling Holders , in connection with the registration or qualification (or exemption from such registration or qualification) of such Registrable Securities for
      offer and sale under the securities or blue sky laws (“Blue Sky”) of all jurisdictions within the United States that the selling Holders request in writing be covered, to
      keep each such registration or qualification (or exemption therefrom) effective during the applicable Effectiveness Period and to do any and all other acts or things necessary or advisable to enable the disposition in such jurisdictions of the
      Registrable Securities covered by any Registration Statement; provided, that the Company will not be required to qualify generally to do business in any jurisdiction where it is not then so qualified or to become subject to any material tax in any
      such jurisdiction where it is not then so subject.

    

    

    (n)        Subsequent Form S-3.  If, at the time of filing of a Registration Statement, the Company is not eligible to use Form S-3 for transactions involving secondary offerings and the Company is not otherwise
      eligible to incorporate by reference prospectively into such Registration Statement, then at such time as the Company becomes eligible to register transactions involving secondary offerings on Form S-3, the Company may, in its sole discretion, file
      in accordance with the procedures outlined in this Section 3, including but not limited to all required notices to the Holders, an additional Registration Statement on Form S-3 to cover resales pursuant to Rule 415 of the Registrable Securities (a “Subsequent Form S-3”), and, when such Subsequent Form S-3 has been filed with the Commission, the Company may, concurrently with its filing of a request for acceleration of
      effectiveness of such Subsequent Form S-3, withdraw or terminate the original Registration Statement; provided, however, that nothing in this Section 3(n) will be interpreted to limit the Company’s obligations pursuant to Section 2(a).

    

    

    
      9

      
        

    

    
      4. Registration Expenses.

    

    

    

    All fees and expenses incident to the performance of or compliance with this Agreement by the Company will be borne by the Company whether or not any
      Registrable Securities are sold pursuant to a Registration Statement including, without limitation: (i) all registration and filing fees (including, without limitation, fees and expenses (A) with respect to filings required to be made with any
      Trading Market on which the Common Stock is then listed for trading, (B) related to compliance with applicable state securities or Blue Sky laws and (C) incurred in connection with the preparation or submission of any filing with FINRA); (ii)
      printing expenses (including, without limitation, expenses of printing certificates for Registrable Securities and of printing Prospectuses); (iii) messenger, telephone and delivery expenses; (iv) fees and disbursements of counsel for the Company and
      counsel pursuant to Section 3(l); (v) Securities Act liability insurance, if the Company so desires such insurance; (vi) fees and expenses of all other persons retained by the Company in connection with the consummation of the transactions
      contemplated by this Agreement and (vii) all of the Company’s own internal expenses incurred in connection with the consummation of the transactions contemplated by this Agreement (including, without limitation, all salaries and expenses of its
      officers and employees performing legal or accounting duties), the expense of any annual audit and the fees and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange as required hereunder; provided,
      however, that each selling Holder will pay (i) all underwriting discounts, commissions, fees and expenses and all transfer taxes with respect to the Registrable Securities sold by such selling Holder; (ii) any fees and expenses of legal counsel other
      than the counsel selected pursuant to Section 3(l) and (iii) all other expenses incurred by such selling Holder and incidental to the sale and delivery of the shares to be sold by such Holder.

    

    

    
      5. Indemnification.

    

    

    

    (a)         Indemnification

          by the Company.  The Company will, notwithstanding any termination of this Agreement, indemnify and hold harmless each Holder, the officers, directors, partners, members and shareholders of each Holder and each person who controls
      any Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) and the directors and officers of any such controlling persons, to the fullest extent permitted by applicable law, from and against any and all
      losses, claims, damages, liabilities, costs (including, without limitation, reasonable costs of preparation and reasonable attorneys’ fees) and expenses (collectively, “Losses”),

      as incurred, arising out of or based upon, in the case of the Registration Statement or in any amendments thereto, any untrue or alleged untrue statement of a material fact contained therein or any omission or alleged omission to state therein a
      material fact required to be stated therein to make the statements not misleading, or in the case of any Prospectus or form of prospectus, or in any amendment or supplement thereto, or in any preliminary prospectus, any untrue or alleged untrue
      statement of a material fact contained therein or any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made,
      not misleading, except to the extent, but only to the extent, that such untrue statements or omissions (1) are made in reliance upon and in conformity with written information furnished to the Company by or on behalf of any Holder expressly for use
      in a Registration Statement, or to the extent that such information relates to such Holder or such Holder’s proposed method of distribution of Registrable Securities and was reviewed and approved in writing by such Holder for use in the Registration
      Statement, such Prospectus or such form of Prospectus (it being understood and agreed that the only such information furnished to the Company by or on behalf of any Holder consists of the information described in Annex A hereto, as may be amended in
      accordance with the provisions of this Agreement, for this purpose) or (2) resulted from the use by any Holder of an outdated or defective Prospectus after the Company has notified such Holder in writing that such Prospectus is outdated or defective
      and prior to the receipt by such Holder of an Advice or an amended or supplemented Prospectus, but only if and to the extent that following the receipt of the Advice or the amended or supplemented Prospectus the misstatement or omission giving rise
      to such Loss would have been corrected. 

    

    

    
      10

      
        

    

    (b)        Indemnification by Holders.  Each Holder will, severally and not jointly, indemnify and hold harmless the Company, its directors, officers, partners, members and shareholders and each
      person who controls the Company (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) and the directors and officers of such controlling person, in each case to the fullest extent permitted by applicable law from
      and against all Losses, as incurred, arising solely out of or based upon, in the case of the Registration Statement or in any amendments thereto, any untrue or alleged untrue statement of a material fact contained therein or any omission or alleged
      omission to state therein a material fact required to be stated therein to make the statements not misleading, or in the case of any Prospectus or form of prospectus, or in any amendment or supplement thereto, or in any preliminary prospectus, any
      untrue or alleged untrue statement of a material fact contained therein or any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
      under which they were made, not misleading to the extent, but only to the extent, that such untrue statements or omissions (1) are made in reliance upon and in conformity with written information furnished to the Company by or on behalf of any Holder
      expressly for use in a Registration Statement or Prospectus, or to the extent that such information relates to such Holder or such Holder’s proposed method of distribution of Registrable Securities and was reviewed and approved in writing by such
      Holder for use in the Registration Statement or Prospectus (it being understood and agreed that the only such information furnished to the Company by or on behalf of any Holder consists of the information described in Annex A hereto, as may be
      amended in accordance with the provisions of this Agreement, for this purpose) or (2) resulted from the use by such Holder of an outdated or defective Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated or
      defective and prior to the receipt by such Holder of an Advice or an amended or supplemented Prospectus, but only if and to the extent that following the receipt of the Advice or the amended or supplemented Prospectus the misstatement or omission
      giving rise to such Loss would have been corrected; provided, however, that the obligation to indemnify will be several and not joint and in no event will the liability of any selling Holder hereunder be greater in amount than the dollar amount of
      the net proceeds received by any such selling Holder upon the sale of the Registrable Securities under the Registration Statement giving rise to such indemnification obligation.

    

    

    (c)          Conduct of Indemnification Proceedings.  In order for a Person (the “Indemnified Party”) to be entitled to any
      indemnification provided for under this Agreement in respect of, arising out of or involving a claim or demand made by any Person against the Indemnified Party (a “Claim”),
      such Indemnified Party must notify the indemnifying party (“Indemnifying Party”) in writing, and in reasonable detail, of the Claim as promptly as reasonably possible after
      receipt by such Indemnified Party of notice of the Claim; provided, however, that failure to give such notification on a timely basis shall not affect the indemnification provided hereunder except to the extent the Indemnifying Party shall have been
      actually materially prejudiced as a result of such failure.  Thereafter, the Indemnified Party shall deliver to the Indemnifying Party, promptly after the Indemnified Party’s receipt thereof, copies of all notices and documents (including court
      filings and related papers) received by the Indemnified Party relating to the Claim.

    

    

    If a Claim is made against an Indemnified Party, the Indemnifying Party shall be entitled to participate in the defense thereof and, if it so chooses
      and acknowledges its obligation in writing to indemnify the Indemnified Party therefor, to assume at its cost the defense thereof with counsel selected by the Indemnifying Party and reasonably satisfactory to the Indemnified Party and to settle such
      suit, action, claim or proceeding in its discretion with an unconditional full release of the Indemnified Party and no admission of fault, liability, culpability or a failure to act by or on behalf of the Indemnified Party.  Notwithstanding any
      acknowledgment made pursuant to the immediately preceding sentence, the Indemnifying Party shall continue to be entitled to assert any limitation to the amount of Losses for which the Indemnifying Party is responsible pursuant to its indemnification
      obligations.  Should the Indemnifying Party so elect to assume the defense of a Claim, the Indemnifying Party shall not be liable to the Indemnified Party for legal expenses subsequently incurred by the Indemnified Party in connection with the
      defense thereof unless (i) the Indemnifying Party has materially failed to defend, contest or otherwise protest in a timely manner against Claims or (ii) such Indemnified Party reasonably objects to such assumption on the grounds that there are
      defenses available to it which are different from or in addition to the defenses available to such Indemnifying Party and, as a result, a conflict of interest exists.  Subject to the limitations in the preceding  sentence, if the Indemnifying Party
      assumes such defense, the Indemnified Party shall have the right to participate in the defense thereof and to employ counsel, at its own expense, separate from the counsel employed by the Indemnifying Party, it being understood, however, that the
      Indemnifying Party shall control such defense.  The Indemnifying Party shall be liable for the fees and expenses of counsel employed by the Indemnified Party for any period during which the Indemnifying Party has not assumed the defense thereof.  If
      the Indemnifying Party chooses to defend any Claim, all the parties hereto shall cooperate in the defense or prosecution of such Claim.  Such cooperation shall include the retention and (upon the Indemnifying Party’s request) the provision to the
      Indemnifying Party of records and information which are reasonably relevant to such Claim, and making employees available on a mutually convenient basis to provide additional information and explanation of any material provided hereunder.  Whether or
      not the Indemnifying Party shall have assumed the defense of a Claim, the Indemnified Party shall not admit any liability with respect to, or settle, compromise or discharge, such Claim without the Indemnifying Party’s prior written consent (which
      consent shall not be unreasonably withheld).

    

    

    
      11

      
        

    

    The obligations of the Company and the Holders under this Section 5 shall survive completion of any offering of Registrable Securities pursuant to a
      Registration Statement and the termination of this Agreement.  The Indemnifying Party’s liability to any such Indemnified Party hereunder shall not be extinguished solely because any other Indemnified Party is not entitled to indemnity hereunder.

    

    

    (d)         Contribution.  If a claim for indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party (by reason of public policy or otherwise), then each Indemnifying Party, in
      lieu of indemnifying such Indemnified Party, will contribute to the amount paid or payable by such Indemnified Party as a result of such Losses, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and
      Indemnified Party in connection with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations.  The relative fault of such Indemnifying Party and Indemnified Party will be determined by
      reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact, has been taken or made by, or relates to information supplied
      by, such Indemnifying Party or Indemnified Party, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission.  The amount paid or payable by a party as a result of any
      Losses will be deemed to include, subject to the limitations set forth in Section 5(c), any reasonable attorneys’ or other reasonable fees or expenses incurred by such party in connection with any Proceeding to the extent such party would have been
      indemnified for such fees or expenses if the indemnification provided for in Section 5(a) or 5(b) was available to such party in accordance with its terms.  The parties hereto agree that it would not be just and equitable if contribution pursuant to
      this Section 5 were determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to in this Section 5.  Notwithstanding the provisions of this Section 5, no Holder will
      be required to contribute, in the aggregate, any amount in excess of the amount by which the proceeds actually received by such Holder from the sale of the Registrable Securities subject to the Proceeding exceeds the amount of any damages that such
      Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission.  No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be
      entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation.

    

    

    (e)          Other.  The indemnity and contribution agreements contained in this Section 5 are in addition to any liability that the Indemnifying Parties may have to the Indemnified Parties.

    

    

    
      6.           Miscellaneous.

    

    

    

    (a)        Notices.  All notices or other communications hereunder will be in writing and will be given by (i) personal delivery, (ii) courier or other delivery service which obtains a receipt
      evidencing delivery, (iii) registered or certified mail (postage prepaid and return receipt requested) or (iv) facsimile or similar electronic device, to such address as may be designated from time to time by the relevant party, and which will
      initially be:

    

    

    
      12

      
        

    

    (i)            in the case of the Company:

    Venus Concept Inc.

    235 Yorkland Blvd., Suite 900

    Toronto, Ontario, Canada

    M2J 4Y8

    Attn: General Counsel and Corporate Secretary

    Email: mmandarello@venusconcept.com

    

    

    With a copy to:

    

    

    Dorsey & Whitney LLP

    TD Canada Trust Tower

    Brookfield Place 161 Bay Street, Suite 4310

    Toronto, ON M5J 2S1

    Attn:  Richard Raymer

    Email:  raymer.richard@dorsey.com

    

    

    (ii)          in the case of each Purchaser, to
          the address described in Section 5.4 of the Purchase Agreement.

     

        

    Notices to Holders shall be provided to the address specified on such Holder’s Selling Holder Questionnaire.  All notices and other communications
      will be deemed to have been given (i) if delivered by the United States mail, three (3) Business Days after mailing (five (5) Business Days if delivered to an address outside of the United States), (ii) if delivered by a courier or other delivery
      service, one (1) Business Day after dispatch (two (2) Business Days if delivered to an address outside of the United States) and (iii) if personally delivered or sent by facsimile or similar electronic device, upon receipt by the recipient or its
      agent or employee (which, in the case of a notice sent by facsimile or similar electronic device, will be the time and date indicated on the transmission confirmation receipt).  No objection may be made by a party to the manner of delivery of any
      notice actually received in writing by an authorized agent of such party.

    

    

    (b)         Governing Law; Jurisdiction; Jury Trial; Etc..  This Agreement shall be governed by, and construed in accordance with, the internal laws of the State of New York.  Each party hereby
      irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated
      hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought
      in an inconvenient forum or that the venue of such suit, action or proceeding is improper.  Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy
      thereof to such party at the address for such notices to it under this Agreement and agrees that such service will constitute good and sufficient service of process and notice thereof.  Nothing contained herein will be deemed to limit in any way any
      right to serve process in any manner permitted by law.  Each party hereby irrevocably waives any right it may have, and agrees not to request, a jury trial for the adjudication of any dispute hereunder or in connection with or arising out of this
      Agreement or any transaction contemplated hereby.

    

    

    (c)         Remedies.  In the event of a breach by the Company of its obligations under this Agreement, each Holder, in addition to being entitled to exercise all rights granted by law,  including
      recovery of damages, will be entitled to specific performance of its rights under this Agreement.  The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of any of the provisions
      of this Agreement and hereby waives the defense in any action for specific performance that a remedy at law would be adequate.

    

    

    
      13

      
        

    

    (d)        Complete Agreement; Modifications.  This Agreement and any documents referred to herein or executed contemporaneously herewith constitute the parties’ entire agreement with respect to the
      subject matter hereof and supersede all agreements, representations, warranties, statements, promises and understandings, whether oral or written, with respect to the subject matter hereof.  This Agreement may be amended, altered or modified only by
      a writing signed by the Company and the Holders of a majority of the Registrable Securities then outstanding.

    

    

    (e)          Additional Documents.  Each party hereto agrees to execute any and all further documents and writings and to perform such other actions which may be or become necessary or expedient to
      effectuate and carry out this Agreement.

    

    

    (f)          Third-Party Beneficiaries.  None of the provisions of this Agreement will be for the benefit of, or enforceable by, any third-party beneficiary, except with respect to the Holders.

    

    

    (g)          Successors and Assigns.  Except as provided herein to the contrary, this Agreement will be binding upon and inure to the benefit of the parties, their respective successors and permitted
      assigns.

    

    

    (h)        Waivers Strictly Construed.  With regard to any power, remedy or right provided herein or otherwise available to any party hereunder (a) no waiver or extension of time will be effective
      unless expressly contained in a writing signed by the waiving party and (b) no alteration, modification or impairment will be implied by reason of any previous waiver, extension of time, delay or omission in exercise, or other indulgence.

    

    

    (i)           Severability.  The validity, legality or enforceability of the remainder of this Agreement will not be affected even if one or more of the provisions of this Agreement will be held to be
      invalid, illegal or unenforceable in any respect.

    

    

    (j)          Attorneys’ Fees.  Should any litigation be commenced (including any proceedings in a bankruptcy court) between the parties hereto or their representatives concerning any provision of this
      Agreement or the rights and duties of any person or entity hereunder, the party or parties prevailing in such proceeding will be entitled, in addition to such other relief as may be granted, to the attorneys’ fees and court costs incurred by reason
      of such litigation.

    

    

    (k)         Headings.  The Section headings in this Agreement are inserted only as a matter of convenience, and in no way define, limit, extend or interpret the scope of this Agreement or of any
      particular Section.

    

    

    (l)           Counterparts.  This Agreement may be executed simultaneously in two or more counterparts, each of which will be deemed an original, but all of which together will constitute one and the
      same instrument.

    

    

    [Remainder of Page Intentionally Left Blank, Signature Pages to Follow]

     

    

    
      14

      
        

    

    IN WITNESS WHEREOF, the parties
        have executed this Resale Registration Rights Agreement as of the date first written above.

    

    

    	 	
            VENUS CONCEPT INC.

          
	 	 
	 	
            By:

          	/s/ Domenic Serafino

          	 
	 	
            Name: Domenic Serafino

          
	 	
            Title: CEO

            

          

     

    

    [Signature Page to Resale Registration Rights Agreement]

    
      
        

    

    IN WITNESS WHEREOF, the parties have
        executed this Resale Registration Rights Agreement as of the date first written above.

    

    

    	 	PURCHASERS:

          
	 	 
	 	
            MARLIN FUND, LIMITED PARTNERSHIP

          
	 	 
	 	
            By:

          	/s/ Michael W. Masters

          	 
	 	
            Name: Michael W. Masters

          
	 	
            Title: Managing Member of the General Partner

            

          
	 	 
	 	
            MARLIN FUND II, LIMITED PARTNERSHIP

          
	 	 
	 	
            By:

          	/s/ Michael W. Masters	 
	 	
            
              Name: Michael W. Masters

            

          
	 	
            Title: Managing Member of the General Partner

          
	 	 
	 	
            MARLIN FUND III, LIMITED PARTNERSHIP

          
	 	 
	 	
            By:

          	/s/ Michael W. Masters	 
	 	
            
              Name: Michael W. Masters

            

          
	 	Title: Managing Member of the General Partner
	 	 
	 	
            MARLIN MASTER FUND OFFSHORE II, LP

          
	 	 
	 	
            By:

          	/s/ Michael W. Masters	 
	 	
            
              Name: Michael W. Masters

            

          
	 	
            Title: Managing Member of the General Partner

          
	 	 
	 	
            MSS VC SPV LP

          
	 	 
	 	
            By: MSS VC SPV GP, LLC, its general partner

          
	 	

          
	 	
            By: Masters Special Situations, LLC, its managing member

          
	 	 
	 	
            By:

          	/s/ Michael W. Masters	 
	 	
            
              Name: Michael W. Masters

            

          
	 	Title: Managing Member
	 	 
	 	
            MASTERS SPECIAL SITUATIONS, LLC

          
	 	 
	 	
            By:  

          	/s/ Michael W. Masters	 
	 	
            Name:  Michael W. Masters

          
	 	
            Title:  Managing Member

          

    

    

    [Signature Page to Resale Registration Rights Agreement]

    
      
        

    

    	 	
            EW HEALTHCARE PARTNERS, L.P.

          
	 	 
	 	
            By:

          	
            /s/ Scott Barry

          	 
	 	
            Name: Scott Barry

          
	 	
            Title: Its Authorized Signatory

          
	 	 
	 	
            EW HEALTHCARE PARTNERS-A, L.P.

          
	 	 
	 	
            By:

          	
            /s/ Scott Barry

          	 
	 	
            Name: Scott Barry

          
	 	
            
              Title: Its Authorized Signatory

            

          

    

    

    [Signature Page to Resale Registration Rights Agreement]

    
      
        

    

    	 	
            HEALTHQUEST PARTNERS II, L.P.

          
	 	 
	 	
            By:

          	
            /s/ Gerheng Kong

          	 
	 	
            Name: Gerheng Kong

          
	 	
            Title: Managing Partner

          

    

    

    [Signature Page to Resale Registration Rights Agreement]

    
      
        

    

    	 	
            KEITH J SULLIVAN TRUSTEE

          
	 	
            UAD 11/04/2016

          
	 	
            KEITH J SULLIVAN REVOCABLE TRUST

          
	 	 
	 	
            By:

          	
            /s/ Keith Sullivan

          	 
	 	
            Name: Keith Sullivan

          
	 	
            Title: President & CEO

          

    

    

    [Signature Page to Resale Registration Rights Agreement]

    
      
        

    

    
    PLAN OF DISTRIBUTION

    

    

    We are registering the Securities covered by this prospectus on behalf of the Selling Securityholders.  All costs, expenses and fees connected with
      the registration of these Securities will be borne by us.  Any brokerage commissions and similar expenses connected with selling the Securities will be borne by the Selling Securityholders.  The Selling Securityholders may offer and sell the
      Securities covered by this prospectus from time to time in one or more transactions. The term “Selling Securityholders” includes pledgees, donees, transferees and other
      successors-in-interest who may acquire Securities through a pledge, gift, partnership distribution or other non-sale related transfer from the Selling Securityholders.  The Selling Securityholders will act independently of the Company in making
      decisions with respect to the timing, manner and size of each sale.  These  transactions include:

    

    

    	

          	•	
            in “at the market offerings” within the meaning of Rule 415(a)(4) under the Securities Act, to or through a market maker or into an existing trading market, on an exchange or otherwise;

          

    

    

    	

          	•	
            directly to a limited number of purchasers or to a single purchaser;

          

    

    

    	

          	•	
            through agents;

          

    

    

    	

          	•	
            by delayed delivery contracts or by remarketing firms;

          

    

    

    	

          	•	
            ordinary brokerage transactions and transactions in which the broker solicits purchasers;

          

    

    

    	

          	•	
            purchases by a broker-dealer as principal and resale by the broker-dealer for its own account pursuant to this prospectus;

          

    

    

    	

          	•	
            exchange or over-the-counter distributions in accordance with the rules of the exchange or other market;

          

    

    

    	

          	•	
            block trades in which the broker-dealer attempts to sell the Securities as agent but may position and resell a portion of the block as principal to facilitate the transaction, or in crosses, in which the same
              broker acts as agent on both sides of the trade;

          

    

    

    	

          	•	
            transactions in options, swaps or other derivatives that may or may not be listed on an exchange;

          

    

    

    	

          	•	
            through distributions by a Selling Securityholder or its successors in interest to its members, general or limited partners or shareholders (or their respective members, general or limited partners or
              shareholders);

          

    

    

    	

          	•	
            a combination of any such method of sale; or

          

    

    

    	

          	•	
            any other method permitted pursuant to applicable law.

          

    

    

    In connection with distributions of the Securities or otherwise, the Selling Securityholders may:

    

    

    	

          	•	
            sell the Securities:

          

    

    

    
      1

      
        

    

    	

          	•	
            in negotiated transactions;

          

    

    

    	

          	•	
            in one or more transactions at a fixed price or prices, which may be changed from time to time;

          

    

    

    	

          	•	
            at market prices prevailing at the times of sale;

          

    

    

    	

          	•	
            at prices related to such prevailing market prices; or

          

    

    

    	

          	•	
            at negotiated prices;

          

    

    

    	

          	•	
            sell the Securities:

          

    

    

    	

          	•	
            on a national securities exchange;

          

    

    

    	

          	•	
            in the over-the-counter market; or

          

    

    

    	

          	•	
            in transactions otherwise than on an exchange or in the over-the-counter market, or in combination;

          

    

    

    	

          	•	
            enter into option or other transactions with broker-dealers or other financial institutions which require the delivery to them of Securities covered by this prospectus, which they may in turn resell; and

          

    

    

    	

          	•	
            pledge Securities to broker-dealers or other financial institutions, which, upon a default, they may in turn resell.

          

    

    

    The Selling Securityholders may also resell all or a portion of the Securities in open market transactions in reliance upon Rule 144 under the
      Securities Act of 1933, as amended, or the Securities Act, as permitted by that rule, Section 4(a)(1) under the Securities Act, if available, or any other exemption from the registration requirements that become available, rather than under this
      prospectus.

    

    

    If underwriters are used in the sale of any Securities, such Securities will be acquired by the underwriters for their own account and may be resold
      from time to time in one or more transactions described above.  Securities may be either offered to the public through underwriting syndicates represented by managing underwriters or directly by underwriters.  We may use underwriters with whom we
      have a material relationship.  As applicable, we will describe in each accompanying prospectus supplement the name of the underwriter(s) and the nature of any such relationship(s).

    

    

    Securities may be sold directly or through agents designated from time to time.  We will name any agent involved in the offering and sale of such
      shares and we will describe any commissions paid to the agent in the prospectus supplement.  Unless the prospectus supplement states otherwise, the agent will act on a best-efforts basis for the period of its appointment.

    

    

    Agents may be entitled to indemnification by us against certain civil liabilities, including liabilities under the Securities Act, or to contribution
      with respect to payments made by the agents, under agreements between us and the agents.

    

    

    Agents may receive compensation in the form of discounts, concessions or commissions from us or our purchasers, as their agents in connection with the
      sale of securities.  These agents may be considered to be underwriters under the Securities Act.  As a result, discounts, commissions or profits on resale received by the agents may be treated as underwriting discounts and commissions.  Each
      accompanying prospectus supplement will identify any such agent and describe any compensation received by them from us.

    

    

    
      2

      
        

    

    In connection with sales of Securities, the Selling Securityholders may enter into hedging transactions with broker-dealers or other financial
      institutions, which may in turn engage in short sales of Securities in the course of hedging in positions they assume.  The Selling Securityholders may also sell Securities short and the Selling Securityholders may deliver Securities covered by this
      prospectus to close out short positions and to return borrowed Securities in connection with such short sales.  The Selling Securityholders may also loan or pledge Securities to broker-dealers that in turn may sell such Securities, to the extent
      permitted by applicable law.  The Selling Securityholders may also enter into option or other transactions with broker-dealers or other financial institutions or the creation of one or more derivative securities which require the delivery to such
      broker-dealer or other financial institution of Securities offered by this prospectus, which Securities such broker-dealer or other financial institution may resell pursuant to this prospectus  (as supplemented or amended to reflect such
      transaction).

    

    

    The Selling Securityholders may, from time to time, pledge or grant a security interest in some or all of the Securities owned by them and, if they
      default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the Securities from time to time pursuant to this prospectus or any amendment to this prospectus under Rule 424(b)(3) or other applicable
      provision of the Securities Act, amending, if necessary, the list of Selling Securityholders to include the pledgee, transferee or other successors in interest as Selling Securityholders under this prospectus.  The Selling Securityholders may also
      may transfer and donate Securities in other circumstances in which case the transferees, donees, pledgees or other successors in interest will be the selling beneficial owners for purposes of this prospectus.

    

    

    A Selling Securityholder that is an entity may elect to make an in-kind distribution of Securities to its members, general or limited partners or
      shareholders pursuant to the registration statement of which this prospectus is a part by delivering a prospectus. To the extent that such members, general or limited partners or shareholders are not affiliates of ours, such members, partners or
      shareholders would thereby receive freely tradable Securities pursuant to the distribution through a registration statement. Additionally, to the extent that entities, members, partners or shareholders are affiliates of ours received shares in any
      such distribution, such affiliates will also be Selling Securityholders and will be entitled to sell Securities pursuant to this prospectus.

    

    

    Agents who may become involved in the sale of Securities may engage in transactions with, and perform other services for, us in the ordinary course of
      their business for which they receive compensation.

    

    

    In effecting sales, the Selling Securityholders may engage broker-dealers or agents, who may in turn arrange for other broker-dealers to participate. 
      Broker-dealers or agents may receive commissions, discounts or concessions from the Selling Securityholders and/or from the purchasers of Securities for whom the broker-dealers may act as agents or to whom they sell as principal, or both.  The
      compensation to a particular broker-dealer may be in excess of customary commissions.  To our knowledge, there is currently no plan, arrangement or understanding between any Selling Securityholders and any broker-dealer or agent regarding the sale of
      any Securities by the Selling Securityholders.

    

    

    The Selling Securityholders, any broker-dealers or agents and any participating broker-dealers that act in connection with the sale of the Securities
      covered by this prospectus may be “underwriters” under the Securities Act with respect to those Securities and will be subject to the prospectus delivery requirements of that Act.  Any profit that the Selling Securityholders realize, and any
      compensation that any broker-dealer or agent may receive in connection with any sale, including any profit realized on resale of Securities acquired as principal, may constitute underwriting discounts and commissions.  If the Selling Securityholders
      are deemed to be underwriters, the Selling Securityholders may be subject to certain liabilities under statutes including, but not limited to, Section 11, 12 and 17 of the Securities Act and Section 10(b) and Rule 10b-5 under the Exchange Act.

    

    

    
      3

      
        

    

    The securities laws of some states may require the Selling Securityholders to sell the Securities in those states only through registered or licensed
      brokers or dealers.  These laws may also require that we register or qualify the Securities for sale in those states unless an exemption from registration and qualification is available and the Selling Securityholders and we comply with that
      exemption.  In addition, the anti-manipulation rules of Regulation M under the Securities Exchange Act of 1934 may apply to sales of Securities in the market and to the activities of the Selling Securityholders and their affiliates.  Regulation M may
      restrict the ability of any person engaged in the distribution of the Securities to engage in market-making activities with respect to the Securities.  All of the foregoing may affect the marketability of the Securities and the ability of any person
      to engage in market-making activities with respect to the Securities.

    

    

    If any Selling Securityholder notifies us that he has entered into any material arrangement with a broker-dealer for the sale of Securities through a
      block trade, special offering, exchange distribution, over‐the-counter distribution or secondary distribution, or a purchase by a broker or dealer, we will file any necessary supplement to this prospectus to disclose:

    

    

    	

          	•	
            the number of Securities involved in the arrangement;

          

    

    

    	

          	•	
            the terms of the arrangement, including the names of any underwriters, dealers or agents who purchase Securities, as required;

          

    

    

    	

          	•	
            the proposed selling price to the public;

          

    

    

    	

          	•	
            any discount, commission or other underwriting compensation;

          

    

    

    	

          	•	
            the place and time of delivery for the Securities being sold;

          

    

    

    	

          	•	
            any discount, commission or concession allowed, reallowed or paid to any dealers; and

          

    

    

    	

          	•	
            any other material terms of the distribution of Securities.

          

    

    

    In addition, if the Selling Securityholder notifies us that a donee, pledgee, transferee or other successor-in-interest of the
      Selling Securityholder intends to sell any securities, we will file an amendment to the registration statement of which this prospectus forms a part of or a supplement to this prospectus, if required.

    
      4

      
        

    

    VENUS CONCEPT INC.

    

    

    SELLING SECURITYHOLDER NOTICE AND QUESTIONNAIRE

    

    

    The undersigned beneficial owner of common stock, $0.0001 par value per share (the “Common Stock”)

      and/or securities, of Venus Concept Inc.  (the “Company”) understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a Registration Statement for the registration and resale of the Registrable Securities, in accordance with the terms of the Registration Rights Agreement, dated as of December 15, 2021 (the “Registration Rights Agreement”), among the Company and the Purchasers (as defined therein).  A copy of the Registration Rights Agreement is available from the Company upon request at the address
      set forth below.  All capitalized terms used and not otherwise defined herein will have the meanings ascribed thereto in the Registration Rights Agreement.

    

    

    The undersigned hereby provides the following information to the Company and represents and warrants that such information is accurate:

    

    

    
      	
              1.

            	
              Name.

            

    

    

    

    
      	
              (a)

            	
              Full Legal Name of Selling Securityholder

            
	 	 
	 	 
	
              (b)

            	
              Full Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Securities Listed in Item 3 below are held:

            
	 	 
	 	 
	
              (c)

            	
              Full Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone or with others has power to vote or dispose of the securities covered by the
                questionnaire):

            
	 	 

    

    

    

    
      	
              2.

            	
              Address for Notices to Selling Securityholder:

            

    

    

    

    
      	
              Name:

            	 
	
              Address:

            	 
	 	 
	
              Telephone:

            	 
	
              Fax:

            	 
	
              Contact Person:

            	 

    

    

    

    	3.	
            Beneficial Ownership of Registrable Securities:

          

    

    

    
      	
              (a)

            	
              Type and Amount of Registrable Securities Beneficially Owned:

            
	 	 

    

    

    

    
      5

      
        

    

    	4.	
            Broker-Dealer Status:

          

    

    

    	

          	(a)	
            Are you a broker-dealer?

          

    

    

    Yes ☐  No ☐

    

    

    Note: If yes, the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement.

    

    

    	

          	(b)	
            Are you an affiliate of a broker-dealer?

          

    

    

    Yes ☐  No ☐

    

    

    	

          	(c)	
            If you are an affiliate of a broker-dealer, do you certify that you bought the Registrable Securities in the ordinary course of business, and at the time of the purchase of the Registrable Securities to be resold,
              you had no agreements or understandings, directly or indirectly, with any person to distribute the Registrable Securities?

          

    

    

    Yes ☐  No ☐

    

    

    Note: If no, the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement.

    

    

    	5.	
            Beneficial Ownership of Other Securities of the Company Owned by the Selling Securityholder.

          

    

    

    Except as set forth below in this Item 5, the undersigned is not the beneficial or registered owner of any securities of the Company other than the
      Registrable Securities listed above in Item 3.

     

    

    Type and Amount of Other Securities Beneficially Owned by the Selling Securityholder:

    

    

    
      	 
	 
	 

    

     

    

    	6.	
            Relationships with the Company:

          

    

    

    Except as set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5% of more of
      the equity securities of the undersigned) has held any position or office or has had any other material relationship with the Company (or its predecessors or affiliates) during the past three years.

    

    

    
      	
              State any exceptions here:

            	 
	 
	 

    

    

    

    The undersigned agrees to promptly notify the Company of any inaccuracies or changes in the information provided herein that may occur subsequent to
      the date hereof and prior to the Effective Date for the Registration Statement.

    

    

    
      6

      
        

    

    By signing below, the undersigned consents to the disclosure of the information contained herein in its answers to Items 1 through 6 and the inclusion
      of such information in the Registration Statement and the related prospectus.  The undersigned understands that such information will be relied upon by the Company in connection with the preparation or amendment of the Registration Statement and the
      related prospectus.

    

    

    
      7

      
        

    

    IN WITNESS WHEREOF the undersigned, by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either in person or by its duly authorized agent.

    

    

    	
            Dated:

          	
            Beneficial Owner:

          
	 	 
	 	 	 
	 	
            By:

          	 
	 	
            Name:

          	 
	 	
            Title:

          	 

    

    

    PLEASE FAX A COPY OF THE COMPLETED AND EXECUTED NOTICE AND 

    QUESTIONNAIRE, AND RETURN THE ORIGINAL BY OVERNIGHT MAIL, TO:

    

    

    Venus Concept Inc.

    
      ATTN: Michael Mandarello, General Counsel and Corporate Secretary

      235 Yorkland Blvd., Suite 900

      Toronto, ON M2J 4Y8

    

    

    

    

    

  

  8Exhibit 10.3

        

         

          

        Execution Version

        

        

        

        
          	
                   

                

        

        INVESTOR RIGHTS AGREEMENT

        

        

        by and between

        

        

        VENUS CONCEPT, INC.

      

      
        

        

      

      
        MASTERS SPECIAL SITUATIONS, LLC

        

        

        and

        

        

        THE OTHER PURCHASERS FROM TIME TO TIME PARTY

        HERETO

      

      
        

        

      

      
        Dated as of December 15, 2021

      

      
        	
                 

              

         

        

      

      
        
          

      

      
      TABLE OF CONTENTS

      

      

      	 	
              Page

            
	 	 
	
              ARTICLE I GOVERNANCE

            	
              2

              

            
	 	
              1.1

            	
              Board of Directors

            	
              2

              

            
	 	
              1.2

            	
              Board Nominee

            	
              2

            
	
              ARTICLE II REPRESENTATIONS AND WARRANTIES

            	
              3

            
	 	
              2.1

            	
              Representations and Warranties of the Purchasers

            	
              3

            
	 	
              2.2

            	
              Representations and Warranties of the Company

            	
              3

            
	
              ARTICLE III DEFINITIONS

            	
              4

            
	 	
              3.1

            	
              Defined Terms

            	
              4

            
	 	
              3.2

            	
              Terms Generally

            	
              5

            
	
              ARTICLE IV MISCELLANEOUS

            	
              5

            
	 	
              4.1

            	
              Term

            	
              5

            
	 	
              4.2

            	
              Amendments and Waivers

            	
              5

            
	 	
              4.3

            	
              Successors and Assigns

            	
              5

            
	 	
              4.4

            	
              Severability

            	
              6

            
	 	
              4.5

            	
              Counterparts

            	
              6

            
	 	
              4.6

            	
              Entire Agreement

            	
              6

            
	 	
              4.7

            	
              Governing Law; Jurisdiction

            	
              6

            
	 	
              4.8

            	
              WAIVER OF JURY TRIAL

            	
              6

            
	 	
              4.9

            	
              Specific Performance

            	
              6

            
	 	
              4.10

            	
              No Third-Party Beneficiaries

            	
              6

            
	 	
              4.11

            	
              Notices

            	
              6

            

      

      

      
        -i-

        
          

      

      
      This INVESTOR RIGHTS AGREEMENT, dated as of December 15, 2021 (as may be amended from time to time, this “Agreement”),

        by and among Venus Concept, Inc., a Delaware corporation (the “Company”), Masters Special Situations, LLC (“Masters”) and any other Purchaser (as defined below) that is affiliated with Masters otherwise a party hereto from time to
        time.

      

      

      W I T N E S S
            E T H:

      

      

      WHEREAS, the Company and the Purchasers have entered into a Stock Purchase Agreement, dated as of December 15, 2021 (as may be amended from time to
        time, the “Purchase Agreement”), pursuant to which, among other things, the Company is issuing and selling to the Purchasers shares of Common Stock and Nonvoting Convertible Preferred Stock (collectively, the “Securities”);

      

      

      WHEREAS, simultaneously with the execution and delivery of this Agreement by the parties, the Company and the Purchasers have entered into a
        Registration Rights Agreement, dated as of December 15, 2021 (as may be amended from time to time, the “Registration Rights Agreement”), pursuant to which, among other things, the Company grants the Purchasers certain registration and other
        rights with respect to certain of the Securities; and

      

      

      WHEREAS, each of the parties wishes to set forth in this Agreement certain terms and conditions regarding ownership of the Securities.

      

      

      NOW, THEREFORE, in consideration of circumstances recited above and the mutual covenants, representations, warranties and agreements contained in
        this Agreement, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the parties agree as follows:

      

      

      
        -1-

        
          

      

      ARTICLE I

      

      

      GOVERNANCE

      

      

      1.1         Board of Directors.

      

      

      (a)          At or prior to the Appointment
          Date (as defined below), the board of directors of the Company (the “Board”) shall expand its size, if necessary, to create a vacancy for one (1) qualified nominee of Masters. Masters
          shall have the right to designate, subject to the terms and conditions of this Section 1.1, one nominee to the Board (a “Board Nominee”). The Board shall in good faith consider whether
          any nominee is (i) qualified and suitable to serve as a member of the Board under all applicable corporate governance policies and guidelines of the Company and the Board and applicable legal, regulatory and stock exchange requirements and (ii)
          meets the independence requirements of The NASDAQ Global Market and any other stock exchange on which the Common Stock may be listed in the future. The Board and the appropriate committees of the Board shall conduct the consideration of the
          qualifications, suitability and independence of the Board Nominee, and make any determinations with respect thereto in a manner consistent with considerations and determinations in respect of other members of the Board. Masters shall cause the
          Board Nominee to make himself or herself reasonably available for interviews, to consent to such reference and background checks or other investigations and to provide such information (including information necessary to determine the Board
          Nominee’s independence under various requirements and institutional investor guidelines as well as information necessary to determine any disclosure obligations of the Company) as the Board or any committee thereof may reasonably request;
          provided that in each such case, all such interviews, investigations and information are generally required to be delivered to the Company by the other outside directors of the Company. If the Board determines that the Board Nominee is qualified
          and suitable to serve as a member of the Board under all applicable corporate governance policies and guidelines of the Company and the Board and applicable legal, regulatory and stock exchange requirements, then the Board shall appoint such
          initial Board Nominee to the Board as a Class II director within 30 days following the Closing (the date of such appointment, the “Appointment Date”). Provided that the Board Nominee
          then meets the foregoing requirements, then so long as Masters and its Affiliates beneficially own at least 5% of the outstanding Common Stock, as determined in accordance with Rule 13d-3 of the Exchange Act (the “Nomination Condition”), measured as of the date of mailing of the Company’s proxy statement (or consent solicitation or similar document) of the Company relating to the election of the Board, the Company shall
          nominate the Board Nominee for re-election as a Class II director at the end of each term of such Board Nominee as part of the slate proposed by the Company that is included in the proxy statement (or consent solicitation or similar document) of
          the Company relating to the election of the Board. In the event that the Board determines that the Board Nominee does not meet the foregoing requirements, or if a Board Nominee ceases to be a member of the Board at any time and for any reason, so
          long as the Nomination Condition is satisfied as of such time, Masters may select another person as a designee for Board Nominee and, if the Board determines that such nominee meets the criteria set forth above, such designee shall become a Board
          Nominee and shall be promptly appointed by the Board as a Class II director. The Board shall undertake any review of any such Board Nominee by Masters in accordance with this paragraph and shall complete such review promptly, and in any event
          within ten (10) Business Days following receipt by the Company of the identity of the Board Nominee, provided that during the pendency of such review, such Board Nominee shall promptly provide the Board with such information, and shall make
          themselves available to the Board, as the Board reasonably deems necessary to complete its review of such Board Nominee as contemplated by this Section 1.1.  Notwithstanding anything else contained in this Agreement to the contrary, if at any
          time following the Closing (provided that Masters and its Affiliates then beneficially owns at least 5% of the outstanding Common Stock, as determined in accordance with Rule 13d-3 of the Exchange Act), a Board Nominee is not a member of the
          Board for any reason and a new Board Nominee has not been appointed, Masters shall be entitled to designate an observer at meetings of the Board and all committees thereof, and the Company shall provide all materials that are provided to other
          members of the Board in connection with such meetings to the observer, unless such attendance or the provision of such materials would result in an actual conflict of interest or violate any of the applicable corporate governance policies and
          guidelines or applicable legal, regulatory or stock exchange requirements or would result in the loss of attorney-client privilege.

      

      

      (b)        The Board Nominee shall be
          subject to the policies and requirements of the Company and the Board, in a manner consistent with the application of such policies and requirements to other members of the Board. The Company shall compensate the Board Nominee, and reimburse the
          Board Nominee for their reasonable expenses incurred in connection with Board service, reimburse and advance to the Board Nominee’s expenses, indemnify the Board Nominee, and provide them with coverage pursuant to director and officer insurance
          to the same extent it compensates, reimburses and advances, indemnifies and provides insurance for the other outside members of the Board pursuant to its organizational documents, applicable law or otherwise. The Company agrees that such
          indemnification arrangements will provide that such indemnification, reimbursement and advancement will be the primary source of indemnification and reimbursement and advancement of expenses in connection with the matters covered thereby and
          payment thereon will be made before, offset and reduce any other indemnity or expense reimbursement or advancement to which a Board Nominee may be entitled or which is actually paid in connection with such matters, including as an employee of
          Masters or any of its Affiliates.

      

      

      1.2        Board Nominee. Notwithstanding any provision of this Agreement to the contrary, after the Appointment Date, from the first time when Masters and its Affiliates beneficially own less than 5% of the outstanding
        Common Stock, as determined in accordance with Rule 13d-3 of the Exchange Act, and thereafter in perpetuity (i.e., even if Masters and its Affiliates later come to beneficially own at least 5% of the outstanding Common Stock, as determined in
        accordance with Rule 13d-3 of the Exchange Act), Masters shall no longer have the right to designate any Board Nominee or Board observer, and any Board Nominee then serving on the Board shall immediately resign.

      

      

      
        -2-

        
          

      

      ARTICLE II

      

      

      REPRESENTATIONS AND WARRANTIES

      

      

      2.1         Representations and Warranties of the Purchasers.  The Purchasers, as of the date hereof, and as of the date any such Purchaser becomes a party to this Agreement pursuant to the execution of a joinder, hereby
        represent and warrant to the Company as follows:

      

      

      (a)          Such Purchaser is duly
          organized, validly existing and in good standing, and has the power, authority and capacity to execute and deliver this Agreement (or to deliver a joinder and join this Agreement, as applicable), to perform its obligations hereunder.

      

      

      (b)         This Agreement (or the
          execution and delivery of a joinder and the joining of this Agreement, as applicable) will not violate, conflict with or result in a breach of or default under (i) such Purchaser’s organizational documents, (ii) any Material Agreement (as defined
          in the Purchase Agreement) to which such Purchaser is a party or by which such Purchaser or any of its assets are bound, or (iii) any material laws, regulations or governmental or judicial decrees, injunctions or orders applicable to such
          Purchaser.

      

      

      (c)        This Agreement (or joinder, as
          applicable) has been duly executed and delivered by such Purchaser and constitutes a legal, valid and binding obligation of such Purchaser, enforceable against the Purchaser in accordance with its terms, except as such enforceability may be
          limited by bankruptcy, fraudulent conveyance, insolvency, reorganization, moratorium, and other laws relating to or affecting creditors’ rights generally and by general equitable principles (regardless of whether such enforceability is considered
          in a proceeding in equity or at law).

      

      

      2.2         Representations and Warranties of the Company.  The Company hereby represents and warrants to the Purchasers as of the date hereof as follows:

      

      

      (a)          The Company is duly organized,
          validly existing and in good standing, and has the power, authority and capacity to execute and deliver this Agreement, to perform its obligations hereunder.

      

      

      (b)         The execution, delivery and
          performance by the Company of this Agreement has been duly authorized, and does not (i) conflict with the Company’s organizational documents, (ii) contravene, conflict with, constitute a default under or violate any material law applicable
          thereto, (iii) contravene, conflict or violate any applicable order, writ, judgment, injunction, decree, determination or award of any governmental authority by which the Company may be bound or affected, or (iv) constitute an event of default or
          material breach under any Material Agreement by which the Company, any of its Subsidiaries or any of their respective properties, is bound.  Neither the Company nor any of its Subsidiaries is in default or material breach under any Material
          Agreement to which it is a party or by which it or any of its assets is bound in which such default could reasonably be expected to have a Material Adverse Effect (as defined in the Purchase Agreement).

      

      

      (c)         This Agreement has been duly
          authorized by the Company and constitutes the legal, valid, and binding obligations of the Company, enforceable against the Company in accordance with its terms, except as such enforceability may be limited by bankruptcy, fraudulent conveyance,
          insolvency, reorganization, transfer, moratorium, and other laws relating to or affecting creditors’ rights generally and by general equitable principles (regardless of whether such enforceability is considered in a proceeding in equity or at
          law).

       

        

      
        -3-

        
          

      

      ARTICLE III

      

      

      DEFINITIONS

      

      

      3.1         Defined Terms.  Capitalized terms when used in this Agreement have the following meanings:

      

      

      “Affiliate” means any person or entity that, directly or indirectly through one or more intermediaries, controls or is controlled by or is
        under common control with a person or entity, as such terms are used in and construed under Rule 144 under the Securities Act.  With respect to a Purchaser, any investment fund or managed account that is managed on a discretionary basis by the same
        investment manager as such Purchaser will be deemed to be an Affiliate of such Purchaser. As used in this definition of “Affiliate,” the term “control” means the possession, directly or indirectly, of the power to direct or cause the direction of
        the management and policies of a Person, whether through ownership of voting securities or partnership or other ownership interest, by contract, or otherwise.

      

      

      “Agreement” has the meaning set forth in the Preamble.

      

      

      “Appointment Date” has the meaning set forth in Section 1.1(a).

      

      

      “Board” has the meaning set forth in Section 1.1(a).

      

      

      “Board Nominee” has the meaning set forth in Section 1.1(a).

      

      

      “Business Day” means any day that is not a Saturday, Sunday or a day on which commercial banks in New York, New York are required or
        authorized to be closed.

      

      

      “Closing” has the meaning set forth in the Purchase Agreement.

      

      

      “Common Stock” means the common stock, par value $0.0001 per share of the Company.

      

      

      “Company” has the meaning set forth in the Preamble.

      

      

      “Exchange Act” means the U.S. Securities and Exchange Act of 1934, as amended, and the rules and
        regulations promulgated thereunder.

      

      

      “Masters” has the meaning set forth in the Preamble.

      

      

      “Nomination Condition” has the meaning set forth in Section 1.1(a).

      

      

      “Person” means any individual, sole proprietorship, partnership, limited liability company, joint
        venture, company, trust, unincorporated organization, association, corporation, institution, public benefit corporation, firm, joint stock company, estate, entity or government agency.

      

      

      “Purchase Agreement” has the meaning set forth in the Recitals.

      

      

      “Purchaser” means any of one of the Purchasers.

      

      

      
        -4-

        
          

      

      “Purchasers” means the purchasers of the Securities identified on the signature pages to the Purchase Agreement and each successor and
        assignee that becomes party to the Purchase Agreement.

      

      

      “Registration Rights Agreement” has the meaning set forth in the Recitals.

      

      

      “Securities” has the meaning set forth in the Recitals.

      

      

      “Securities Act” means the U.S. Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

      

      

      “Subsidiary” means, with respect to any Person, any Person of which more than fifty percent (50%) of the voting securities or other equity
        interests (in the case of Persons other than corporations) is owned or controlled, directly or indirectly, by such Person or through one or more intermediaries.

      

      

      3.2        Terms Generally.  The words “hereby,” “herein,” “hereof,” “hereunder” and words of similar import refer to this Agreement as a whole and not merely to the specific section, paragraph or clause in which such word
        appears.  All references herein to “Articles” and “Sections” shall be deemed references to Articles and Sections of this Agreement unless the context shall otherwise require.  The words “include,” “includes” and “including” shall be deemed to be
        followed by the phrase “without limitation.”  References to “$” or “dollars” means United States dollars.  The definitions given for terms in this ARTICLE III and elsewhere in this Agreement shall apply equally to both
        the singular and plural forms of the terms defined.  Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms.  References herein to any agreement or letter shall be deemed references to
        such agreement or letter as it may be amended, restated or otherwise revised from time to time.

      

      

      ARTICLE IV

      

      

      MISCELLANEOUS

      

      

      4.1         Term.  This Agreement will be effective as of the Closing and, except as otherwise set forth herein, will continue in effect thereafter until (a) the mutual written agreement of the Company and the Purchasers
        holding a majority of the shares of Securities to terminate this Agreement or (b) the date that Masters and its Affiliates no longer beneficially own at least 5% of the outstanding Common Stock, as determined in accordance with Rule 13d-3 of the
        Exchange Act.

      

      

      4.2        Amendments and Waivers.  Except as otherwise provided herein, the provisions of this Agreement may be amended or waived only upon the prior written consent of the Company and the Purchasers holding a majority of
        the shares of Securities.  No failure or delay by any party in exercising any right, power or privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or
        the exercise of any other right, power or privilege.  The rights and remedies herein provided shall be cumulative and not exclusive of any right or remedy provided by applicable law.

      

      

      4.3        Successors and Assigns.  Except as otherwise expressly provided in this Section 4.3, neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned by any of the parties
        (whether an initial party or made party through a joinder or otherwise), in whole or in part (whether by operation of law or otherwise), without the prior written consent of the Company and the Purchasers holding a majority of the Securities. 
        Notwithstanding anything to the contrary in the foregoing, (a) subject to the terms and conditions of this Agreement, a Purchaser may assign all or any portion of its rights and interests under this Agreement to any
        Person (i) to which such Purchaser properly assigns or transfers Securities in accordance with the Purchase Agreement, and (ii) that executes a joinder to this Agreement, and (b) this Agreement may be assigned by operation of law by the Company.
        This Agreement will be binding upon, inure to the benefit of, and be enforceable by the parties and their respective permitted successors and assigns. Any attempted assignment in violation of this Section 4.3 shall be null and void ab initio.

      

      

      
        -5-

        
          

      

      4.4        Severability.  Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law, but, if any provision of this Agreement is held to be
        invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or the effectiveness or validity of any such provision in any
        other jurisdiction, and this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein.

      

      

      4.5         Counterparts.  This Agreement may be executed in two (2) or more counterparts, all of which shall be considered one and the same agreement and shall become
        effective when counterparts have been signed by each of the parties and delivered to the other parties, it being understood that each party need not sign the same counterpart.

      

      

      4.6         Entire Agreement.  This Agreement, together with the Purchase Agreement and the other Transaction Documents (as defined in the Purchase Agreement), constitutes the entire agreement among the parties or to which
        they are subject and supersedes all prior agreements and understandings, both written and oral, between the parties with respect to the subject matter of the transactions contemplated hereby and thereby.

      

      

      4.7       Governing Law; Jurisdiction.  THIS AGREEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER AND THEREUNDER SHALL IN ALL RESPECTS BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH, THE INTERNAL LAWS OF THE
        STATE OF NEW YORK, INCLUDING ALL MATTERS OF CONSTRUCTION, VALIDITY AND PERFORMANCE, REGARDLESS OF THE LOCATION OF THE COLLATERAL.

      

      

      4.8        WAIVER OF JURY TRIAL.  EACH OF THE PARTIES HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHTS TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.

      

      

      4.9         Specific Performance.  The parties agree that irreparable damage may occur if any provision of this Agreement is not performed in accordance with the terms hereof and that the parties shall be entitled to seek an
        injunction or injunctions or other equitable relief to prevent breaches of this Agreement or to enforce specifically the performance of the terms and provisions hereof in any court set forth in Section 4.7, in addition to any other remedy
        to which they are entitled at law or in equity.

      

      

      4.10       No Third-Party Beneficiaries.  Nothing in this Agreement shall confer any right upon any Person other than the parties and each such party’s respective heirs, successors and permitted assigns, all of whom shall be
        express third-party beneficiaries of this Agreement.

      

      

      4.11       Notices.  Any notice, request, instruction or other document to be given hereunder by any party to the other will be in writing and will be deemed to have been duly given (a) on the date of delivery if delivered
        personally or by facsimile or electronic communication, upon confirmation of receipt, (b) on the first Business Day following the date of dispatch if delivered by a recognized next-day courier service, or (c) on the third Business Day following the
        date of mailing if delivered by registered or certified mail, return receipt requested, postage prepaid.  All notices hereunder shall be delivered as set forth below, or pursuant to such other instructions as may be designated in writing by the
        party to receive such notice.

      

      

      
        -6-

        
          

      

      If to the Company, to:

      

      

      Venus Concept Inc.

      235 Yorkland Blvd, Suite 900

      Toronto, Ontario, Canada

      M2J 4Y8

      Attn: General Counsel and Corporate Secretary

      Email: mmandarello@venusconcept.com

      

      

      with copies (which shall not constitute notice) to:

      

      

      Dorsey & Whitney LLP

      TD Canada Trust Tower

      Brookfield Place 161 Bay Street, Suite 4310

      Toronto, ON M5J 2S1

      Attn:  Richard Raymer

      Email:  raymer.richard@dorsey.com

      

      

      If to any Purchasers, to the address described in Section 5.4 of the Purchase Agreement.

      

      

      [Remainder of page intentionally left blank]

      

      

      
        -7-

        
          

      

      IN WITNESS WHEREOF, the parties have duly executed this Agreement by their authorized representatives as of the date first above written.

      

      

      	 	
              THE COMPANY:

            
	 	 
	 	
              VENUS CONCEPT, INC.

            
	 	 
	 	
              By:

            	/s/ Domenic Serafino	 
	 	
              Name: Domenic Serafino

            
	 	
              Title: CEO

              

            

      

      

      [Signature Page to Investor Rights Agreement]

      
        
          

      

      	 	
              PURCHASERS:

            
	 	 
	 	
              MARLIN FUND, LIMITED PARTNERSHIP

            
	 	 
	 	
              By:

            	
              /s/ Michael W. Masters

            	 
	 	
              Name:  Michael W. Masters

            
	 	
              Title:  Managing Member of the General Partner

            
	 	 
	 	
              MARLIN FUND II, LIMITED PARTNERSHIP

            
	 	 
	 	
              By:

            	
              /s/ Michael W. Masters

            	 
	 	
              Name:  Michael W. Masters

            
	 	
              Title:  Managing Member of the General Partner

            
	 	 
	 	
              MARLIN FUND III, LIMITED PARTNERSHIP

            
	 	 
	 	
              By:

            	
              /s/ Michael W. Masters

            	 
	 	
              Name:  Michael W. Masters

            
	 	
              Title:  Managing Member of the General Partner

            
	 	 
	 	
              MARLIN MASTER FUND OFFSHORE II, LP

            
	 	 
	 	
              By:

            	
              /s/ Michael W. Masters

            	 
	 	
              Name:  Michael W. Masters

            
	 	
              Title:  Managing Member of the General Partner

            
	 	 
	 	
              MSS VC SPV LP

            
	 	
              By: MSS VC SPV GP, LLC, its general partner

            
	 	
              By: Masters Special Situations, LLC, its managing  member

            
	 	 
	 	
              By:

            	
              /s/ Michael W. Masters

            	 
	 	
              Name:  Michael W. Masters

            
	 	
              Title:  Managing Member

            

      

      

      [Signature Page to Investor Rights Agreement]

      
        
          

      

      	 	
              MASTERS SPECIAL SITUATIONS, LLC

            
	 	 
	 	
              By:

            	
              /s/ Michael W. Masters

            	 
	 	
              Name:  Michael W. Masters

            
	 	
              Title:  Managing Member

            

      

      

      

      

      [Signature Page to Investor Rights Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}]]